1620 Investment Advisors, Inc. Intellia Therapeutics, Inc. Put Options Transaction History
1620 Investment Advisors, Inc.
- $142 Million
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NTLA
# of Institutions
340Shares Held
103MCall Options Held
3.16MPut Options Held
1.56M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.9MShares$104 Million1.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA11MShares$96.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$83.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY6.02MShares$52.4 Million0.01% of portfolio
-
Contrarius Group Holdings LTD Hamilton, D05.89MShares$51.2 Million4.6% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $661M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...